Jazz Pharmaceuticals PLC (JAZZ) Director Bruce Cozadd Sells 6,000 Shares

gurufocus.com · 2026-10-05

Bruce Cozadd, a Director at Jazz Pharmaceuticals PLC (JAZZ), sold 6,000 shares of the company on 2026-10-01, according to a recent SEC Filing. Following thi

TickrTrends take: Jazz Pharmaceuticals is currently assessed as fairly valued by TickrTrends, suggesting the market price aligns reasonably with fundamental metrics in the Healthcare sector. Recent insider selling activity, such as Director Bruce Cozadd's disposition of shares, warrants monitoring to determine whether such transactions reflect confidence constraints or routine portfolio management, particularly as valuation multiples remain in equilibrium. Investors should track patterns in insider transactions alongside any changes to the company's operational performance or sector dynamics that could shift the fairly valued assessment.

Read the full story at gurufocus.com →